In the Amazon, willow bark is used for bark bark, poppy seeds for seeds, and so on.
It's all part of what Brazil's national secretary of bioeconomy calls the country's "knowledge of biodiversity," which has been passed down through generations and is now being used to create new drugs and therapies, the Guardian reports.
"We want to bring our people and communities to the forefront of this agenda so that they may be an integral part of this bioeconomy journey," Carina Pimenta says.
Pimenta spoke at the G20 Bioeconomy Initiative's second meeting in Brazil this week, which focused on the "role of science, technology, research, innovation, and traditional knowledge to bioeconomy," per a press release.
According to the World Business Council for Sustainable Development, bioeconomy is a "business opportunity that circular bioeconomy may now represent."
It's "the business opportunity that circular bioeconomy may now represent," the release notes.
The WBCSD estimates that bioeconomy could bring in7.7 trillion dollars in revenue by 2030, making it "the business opportunity that circular bioeconomy may now represent."
In addition to new drugs and therapies, the press release notes bioeconomy could bring in products like construction materials and packaging, as well Read the Entire Article
A customized collection of grant news from foundations and the federal government from around the Web.
Australia’s Melbourne City Mission Chief Executive Officer Ric Holland writes how philanthropy can act as an enabler on many levels.